GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Remedent REMI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Remedent — daily REMI Delayed
Volume
7k
Shares, 30 Oct 2026

About Remedent

Its shares trade under the ticker REMI. It has been listed since 20 September 2001. In the fiscal year to 31 March 2024, it reported revenue of $1.1m and a net loss of $307,184. At that date it held total assets of $6.1m and shareholders' equity of $2.6m.

Remedent, Inc. engages in the research, development, and manufacturing of oral care and cosmetic dentistry products. The company is headquartered in Ghent, Oost-Vlaanderen. The company went IPO on 2001-09-20. The firm designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The firm's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The firm offers over-the-counter (OTC) tooth whitening products. The company has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The firm has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The firm's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.

Figures and description from our data supplier, not checked against the company's own report.

More about Remedent →

Latest on Remedent

Our reporting

We have not reported on Remedent yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Remedent's ticker?

Remedent trades as REMI on its US listing, under ISIN US75954T1043.

What was Remedent's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.